FDA warns two websites selling Novo, Lilly blockbuster weight loss drugs
The FDA on Tuesday released two warning letters for websites selling unauthorized versions of the blockbuster weight loss and diabetes drugs containing semaglutide, like Ozempic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.